The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHutchmed Share News (HCM)

Share Price Information for Hutchmed (HCM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 310.00
Bid: 307.00
Ask: 312.00
Change: 0.00 (0.00%)
Spread: 5.00 (1.629%)
Open: 311.00
High: 314.00
Low: 303.00
Prev. Close: 310.00
HCM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK Earnings, Trading Statements Calendar - Next 7 Days

Thu, 25th Feb 2021 16:19

Friday 26 February 
ASA International Group PLCTrading Statement
FBD Holdings PLCFull Year Results
Glenveagh Properties PLCFull Year Results
IMI PLCFull Year Results
International Consolidated Airlines Group SAFull Year Results
Law Debenture Corporation PLCFull Year Results
Revolution Bars Group PLCHalf Year Results
Rightmove PLCFull Year Results
RSA Insurance Group PLCFull Year Results
VR Education Holdings PLCFull Year Results
Avation PLCFull Year Results
Monday 1 March 
AFC Energy PLCFull Year Results
Aggreko PLCFull Year Results
Bank of Ireland Group PLCFull Year Results
Bunzl PLCFull Year Results
CentralNic Group PLCFull Year Results
Craneware PLCHalf Year Results
GlobalData PLCFull Year Results
Greencoat Renewables PLCFull Year Results
Medica Group PLCFull Year Results
Mpac Group PLCFull Year Results
Quartix Holdings PLCFull Year Results
Reach PLCFull Year Results
Seplat Petroleum Development Co PLCFull Year Results
Tuesday 2 March 
Apax Global Alpha LtdFull Year Results
Ashtead Group PLCQ3 Results
Bluefield Solar Income Fund LtdHalf Year Results
Croda International PLCFull Year Results
Devro PLCFull Year Results
Flutter Entertainment PLCFull Year Results
Foxtons Group PLCFull Year Results
Fresnillo PLCFull Year Results
Hotel Chocolat Group PLCHalf Year Results
Intertek Group PLCFull Year Results
James Fisher & Sons PLCFull Year Results
PPHE Hotel Group LtdFull Year Results
Renalytix AI PLCHalf Year Results
Robert Walters PLCFull Year Results
Rotork PLCFull Year Results
Signature Aviation PLCFull Year Results
Supermarket Income REIT PLCHalf Year Results
Taylor Wimpey PLCFull Year Results
Travis Perkins PLCFull Year Results
Uniphar PLCFull Year Results
Weir Group PLCFull Year Results
XP Power LtdFull Year Results
Wednesday 3 March 
Avast PLCFull Year Results
Biffa PLCTrading Statement
GetBusy PLCFull Year Results
Hiscox LtdFull Year Results
International Personal Finance PLCFull Year Results
Nichols PLCFull Year Results
PageGroup PLCFull Year Results
Persimmon PLCFull Year Results
Polymetal International PLCFull Year Results
Prudential PLCFull Year Results
Vivo Energy PLCFull Year Results
Thursday 4 March 
Aviva PLCFull Year Results
Admiral Group PLCFull Year Results
Capital & Regional PLCFull Year Results
Coats Group PLCFull Year Results
CRH PLCFull Year Results
Entain PLCFull Year Results
Franchise Brands PLCFull Year Results
Galliford Try Holdings PLCHalf Year Results
Hunting PLCFull Year Results
Hutchison China MediTech LtdFull Year Results
John Laing Group plcFull Year Results
Meggitt PLCFull Year Results
Melrose Industries PLCFull Year Results
Morgan Advanced Materials PLCFull Year Results
Rathbone Brothers PLCFull Year Results
Rentokil Initial PLCFull Year Results
Schroders PLCFull Year Results
Spire Healthcare Group PLCFull Year Results
Synthomer PLCFull Year Results
Tyman PLCFull Year Results
Vesuvius PLCFull Year Results
Vistry Group PLCFull Year Results
William Hill PLCFull Year Results
  
Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
1 Nov 2021 09:14

TOP NEWS: Astra transfers drug rights to Covis in USD270 million deal

TOP NEWS: Astra transfers drug rights to Covis in USD270 million deal

Read more
28 Oct 2021 21:59

IN BRIEF: Hutchmed begins phase 3 trial of thrombocytopenia drug

IN BRIEF: Hutchmed begins phase 3 trial of thrombocytopenia drug

Read more
29 Sep 2021 11:08

Hutchmed China sells joint venture stake for USD169 million

Hutchmed China sells joint venture stake for USD169 million

Read more
21 Sep 2021 10:51

Hutchmed starts drug combination trial for neuroendocrine tumours

Hutchmed starts drug combination trial for neuroendocrine tumours

Read more
20 Sep 2021 09:09

Hutchmed starts Japan trial for surufatinib in neuroendocrine tumors

Hutchmed starts Japan trial for surufatinib in neuroendocrine tumors

Read more
13 Sep 2021 10:22

Hutchmed China's amdizalisib secures breakthrough therapy designation

Hutchmed China's amdizalisib secures breakthrough therapy designation

Read more
8 Sep 2021 13:49

Hutchmed, Astra launch drug combination trial to treat lung cancer

Hutchmed, Astra launch drug combination trial to treat lung cancer

Read more
6 Sep 2021 09:37

Hutchmed China to trade in Shanghai and Shenzhen through link scheme

Hutchmed China to trade in Shanghai and Shenzhen through link scheme

Read more
26 Aug 2021 10:38

Hutchmed launches trial into drug combination to treat breast cancer

Hutchmed launches trial into drug combination to treat breast cancer

Read more
9 Aug 2021 12:35

Hutchmed strikes collaboration deal with Epizyme

(Sharecast News) - Commercial-stage biotechnology company Hutchmed China announced a collaboration to research, develop, manufacture and commercialise 'Tazverik' in Greater China on Monday, including mainland China, Hong Kong, Macau and Taiwan.

Read more
9 Aug 2021 10:06

Hutchmed to partner with Epizyme on tumour-targetting treatment

Hutchmed to partner with Epizyme on tumour-targetting treatment

Read more
28 Jul 2021 14:51

Hutchmed research costs deepen loss; expects US launches in 2022, 2023

Hutchmed research costs deepen loss; expects US launches in 2022, 2023

Read more
28 Jul 2021 11:33

IN BRIEF: Hutchmed and AstraZeneca launch phase two cancer med trial

IN BRIEF: Hutchmed and AstraZeneca launch phase two cancer med trial

Read more
28 Jul 2021 10:58

AIM WINNERS & LOSERS: Hutchmed notes phase 2 trial; Tricorn drops 25%

AIM WINNERS & LOSERS: Hutchmed notes phase 2 trial; Tricorn drops 25%

Read more
21 Jul 2021 16:12

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.